(Abst.) Rituximab in MS: Retrospective observational study on safety and efficacy

MS Speaks »
Forum »
Multiple Sclerosis »
TREATMENTS »
(Abst.) Rituximab in MS: Retrospective observational study on safety and efficacy »
Message #1431

« previous next »

Pages: [1]

Author Topic: (Abst.) Rituximab in MS: Retrospective observational study on safety and efficacy (Read 138 times)

0 Members and 2 Guests are viewing this topic.

agate

Administrator
Posts: 9843
MS diagnosed 1980
Location: Pacific Northwest

Re: (Abst.) Rituximab in MS: Retrospective observational study on safety and efficacy

« on: October 29, 2016, 06:34:51 am »

More about this in MedPage Today (October 28, 2016),"Swedish Registry Supports Rituximab in MS".

Report to moderator

Logged

MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

Pages: [1]

« previous next »

MS Speaks »
Forum »
Multiple Sclerosis »
TREATMENTS »
(Abst.) Rituximab in MS: Retrospective observational study on safety and efficacy »
Message #1431

Related Topics

Subject / Started by	Replies	Last post
MOVED: (Abst.) Efficacy & safety of daclizumab & its potential role in MS treatment Started by agate TREATMENTS	0 Replies 97 Views	May 31, 2016, 01:48:51 pm by agate
(Abst.) Efficacy of rituximab in refractory RRMS Started by agate TREATMENTS	0 Replies 120 Views	May 04, 2018, 02:21:14 pm by agate
(Abst.) Efficacy and safety of ozanimod in MS Started by agate ZEPOSIA (ozanimod)	2 Replies 236 Views	September 08, 2019, 04:17:59 pm by agate
(Abst.) COVID-19 outcomes in MS: Observational study of early experience from NYU MS Center Started by agate MS - RESEARCH AND NEWS	0 Replies 42 Views	July 11, 2020, 02:27:37 pm by agate
MOVED: (Abst.) Safety and efficacy of oral ozanimod in RRMS: phase 2, RADIANCE study Started by agate TREATMENTS	0 Replies 34 Views	December 02, 2020, 03:35:02 pm by agate